In this Issue:
HIV-1 disease progression in elite and viraemic controllers
Maraviroc + darunavir/ritonavir regimen
Didanosine displays transplacental oncogenicity
Sofosbuvir/daclatasvir in HIV/HCV with advanced liver disease
Can or should ART be initiated on the day of diagnosis?
PrEP activity in macaques infected with SHIV
In utero atazanavir exposure: neurodevelopmental problems?
Simplification to darunavir/ritonavir vs lopinavir/ritonavir monotherapy
Cognitive impairment in HIV-1 treated with cART: a multifactorial process
Abandon CD4 counts for those with sustained virological suppression?
Please login below to download this issue (PDF)